Skip to main content

Table 4 Predictive factors for continued administration of tolvaptan for 1 year

From: Impact of continued administration of tolvaptan on cirrhotic patients with ascites

 

Odds ratio

95% confidence interval

p-value

Change in BW after 1 week (kg)

1.320

1.083–1.608

0.006

Albumin (g/dL)

4.280

1.136–16.127

0.032

eGFR (mL/min/1.73 m2)

0.978

0.958–0.999

0.045

  1. Changes in body weight (BW), complications including gastroesophageal varices, hepatocellular carcinoma, and hepatic encephalopathy, and lab values including estimated glomerular filtration rate (eGFR) and serum levels of albumin, total bilirubin, aspartate aminotransferase, and sodium were assessed using multivariate logistic regression analyses
Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us